Global Viral Detection Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Viral Detection market size was valued at US$ 934 million in 2025 and is forecast to a readjusted size of US$ 2484 million by 2032 with a CAGR of 14.9% during review period.
Viral Detection refers to viral safety testing services performed for biologics, vaccines, recombinant proteins, monoclonal antibodies, cell therapies, gene therapies, as well as their raw materials, cell banks, virus seed stocks, unprocessed bulk harvests, and final product lots. It is not a single physical device; rather, it is an integrated quality-control service package composed of testing strategies, standard operating procedures, sample receipt and preparation workflows, indicator cell lines, nucleic-acid amplification systems, sequencing platforms, electron microscopy platforms, reference controls, data-analysis pipelines, and compliant reporting. Its major categories include cell-based in vitro assays, molecular methods such as PCR, qPCR, and ddPCR, broad-range NGS screening, TEM-based morphological identification, and dedicated assays for replication-competent AAV, replication-competent lentivirus, retroviruses, and related viral risks. The technical principle is to identify known or unknown viral contaminants in different sample matrices through viral growth effects, characteristic nucleic-acid sequences, particle morphology, host-range response, and orthogonal confirmation, then determine whether exogenous viral introduction or amplification risks exist in the manufacturing process. This service is mainly provided by CROs, contract testing laboratories, CDMOs with in-house quality platforms, and specialized biologics safety testing organizations. Its key technical requirements focus on sensitivity, specificity, coverage breadth, sample compatibility, contamination control, regulatory compliance, and robust GMP/GLP system execution. Typical use scenarios include cell bank release, raw material release, in-process control, unprocessed bulk testing, final lot release, and contamination investigation.
The expansion of the Viral Detection market is primarily driven by the continued growth of biologics, cell therapies, gene therapies, and novel vaccines. As product complexity rises, a single analytical method is no longer sufficient to cover all viral-risk scenarios, which is accelerating the combined use of cell-based assays, molecular methods, NGS, and electron microscopy. At the same time, updated regulatory frameworks such as ICH Q5A(R2) are bringing risk-based strategies, sample-tiering logic, animal-free alternatives, and faster release concepts to the forefront, pushing Viral Detection from a ?pre-submission compliance task? toward a continuous quality system spanning cell banking, raw materials, process control, lot release, and deviation investigation. For downstream users, building an internal high-grade viral safety platform requires heavy capital, long validation timelines, and difficult maintenance; therefore, outsourcing to specialized organizations with GMP/GLP systems, established methods, and regulatory communication experience has become a practical route to improve efficiency, shorten timelines, and reduce compliance risk.
The main market challenge is no longer whether testing is required, but how to balance accuracy, coverage, speed, cost, and regulatory acceptance. Traditional in vitro and in vivo assays provide broad coverage, but their timelines are longer and sample compatibility can be limited. PCR-based methods are fast and sensitive, but they do not fully address unknown viral threats. NGS is growing rapidly, yet it places higher demands on data interpretation, background-noise control, contamination tracing, method validation, and cross-batch consistency. In cell and gene therapy, complex sample matrices, vector-related signals, and specialized replication-competent virus risks further increase the difficulty of method development and orthogonal confirmation. The industry also faces practical constraints such as cross-region regulatory differences, scheduling bottlenecks, limited expert capacity, and high biosafety requirements. Future competition will therefore center not only on the number of tests offered, but also on platform strength, regulatory alignment, turnaround time, and investigation capability.
Downstream demand is shifting from isolated testing items toward lifecycle-wide testing portfolios. Historically, demand was concentrated on foundational release testing for cell banks and raw materials. Now, more programs are moving Viral Detection upstream into vector construction, donor-material screening, process monitoring, and contamination root-cause tracing, while also extending it downstream into commercial-stage ongoing quality surveillance. Monoclonal antibodies, recombinant proteins, and vaccines remain the most stable demand base, whereas cell therapies, viral vectors, RNA therapeutics, and complex bioprocesses represent the most elastic sources of incremental demand. Supplier selection is also evolving: customers are looking beyond price and increasingly prioritizing integrated capabilities that combine risk assessment, method development, GMP testing, deviation investigation, and global filing support. This will continue to push the market toward platformization, globalization, and higher-value services.
This report is a detailed and comprehensive analysis for global Viral Detection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Viral Detection market size and forecasts, in consumption value ($ Million), 2021-2032
Global Viral Detection market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Viral Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Viral Detection market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Viral Detection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Viral Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Viral Detection, with revenue, gross margin, and global market share of Viral Detection from 2021 to 2026.
Chapter 3, the Viral Detection competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Viral Detection market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Viral Detection.
Chapter 13, to describe Viral Detection research findings and conclusion.
Viral Detection refers to viral safety testing services performed for biologics, vaccines, recombinant proteins, monoclonal antibodies, cell therapies, gene therapies, as well as their raw materials, cell banks, virus seed stocks, unprocessed bulk harvests, and final product lots. It is not a single physical device; rather, it is an integrated quality-control service package composed of testing strategies, standard operating procedures, sample receipt and preparation workflows, indicator cell lines, nucleic-acid amplification systems, sequencing platforms, electron microscopy platforms, reference controls, data-analysis pipelines, and compliant reporting. Its major categories include cell-based in vitro assays, molecular methods such as PCR, qPCR, and ddPCR, broad-range NGS screening, TEM-based morphological identification, and dedicated assays for replication-competent AAV, replication-competent lentivirus, retroviruses, and related viral risks. The technical principle is to identify known or unknown viral contaminants in different sample matrices through viral growth effects, characteristic nucleic-acid sequences, particle morphology, host-range response, and orthogonal confirmation, then determine whether exogenous viral introduction or amplification risks exist in the manufacturing process. This service is mainly provided by CROs, contract testing laboratories, CDMOs with in-house quality platforms, and specialized biologics safety testing organizations. Its key technical requirements focus on sensitivity, specificity, coverage breadth, sample compatibility, contamination control, regulatory compliance, and robust GMP/GLP system execution. Typical use scenarios include cell bank release, raw material release, in-process control, unprocessed bulk testing, final lot release, and contamination investigation.
The expansion of the Viral Detection market is primarily driven by the continued growth of biologics, cell therapies, gene therapies, and novel vaccines. As product complexity rises, a single analytical method is no longer sufficient to cover all viral-risk scenarios, which is accelerating the combined use of cell-based assays, molecular methods, NGS, and electron microscopy. At the same time, updated regulatory frameworks such as ICH Q5A(R2) are bringing risk-based strategies, sample-tiering logic, animal-free alternatives, and faster release concepts to the forefront, pushing Viral Detection from a ?pre-submission compliance task? toward a continuous quality system spanning cell banking, raw materials, process control, lot release, and deviation investigation. For downstream users, building an internal high-grade viral safety platform requires heavy capital, long validation timelines, and difficult maintenance; therefore, outsourcing to specialized organizations with GMP/GLP systems, established methods, and regulatory communication experience has become a practical route to improve efficiency, shorten timelines, and reduce compliance risk.
The main market challenge is no longer whether testing is required, but how to balance accuracy, coverage, speed, cost, and regulatory acceptance. Traditional in vitro and in vivo assays provide broad coverage, but their timelines are longer and sample compatibility can be limited. PCR-based methods are fast and sensitive, but they do not fully address unknown viral threats. NGS is growing rapidly, yet it places higher demands on data interpretation, background-noise control, contamination tracing, method validation, and cross-batch consistency. In cell and gene therapy, complex sample matrices, vector-related signals, and specialized replication-competent virus risks further increase the difficulty of method development and orthogonal confirmation. The industry also faces practical constraints such as cross-region regulatory differences, scheduling bottlenecks, limited expert capacity, and high biosafety requirements. Future competition will therefore center not only on the number of tests offered, but also on platform strength, regulatory alignment, turnaround time, and investigation capability.
Downstream demand is shifting from isolated testing items toward lifecycle-wide testing portfolios. Historically, demand was concentrated on foundational release testing for cell banks and raw materials. Now, more programs are moving Viral Detection upstream into vector construction, donor-material screening, process monitoring, and contamination root-cause tracing, while also extending it downstream into commercial-stage ongoing quality surveillance. Monoclonal antibodies, recombinant proteins, and vaccines remain the most stable demand base, whereas cell therapies, viral vectors, RNA therapeutics, and complex bioprocesses represent the most elastic sources of incremental demand. Supplier selection is also evolving: customers are looking beyond price and increasingly prioritizing integrated capabilities that combine risk assessment, method development, GMP testing, deviation investigation, and global filing support. This will continue to push the market toward platformization, globalization, and higher-value services.
This report is a detailed and comprehensive analysis for global Viral Detection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Viral Detection market size and forecasts, in consumption value ($ Million), 2021-2032
Global Viral Detection market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Viral Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Viral Detection market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Viral Detection
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Viral Detection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Plaque Assays
- PCR
- ELISA
- Others
- Standard Testing Services
- Customized Method Development Services
- Validation Services
- Batch Release Testing Services
- Investigation Services
- Others
- Raw Materials
- Cell Banks
- Viral Seed Stocks / Viral Vectors
- In-Process Samples
- Bulk Harvest / Drug Substance
- Final Product
- Others
- Research Use Only
- Non-GLP / Non-GMP Testing
- GLP-compliant Testing
- GMP-compliant Testing
- Regulatory Submission Support Testing
- Others
- Blood & Blood Products
- Cellular & Gene Therapy Products
- Stem Cell Products
- Tissue & Tissue Products
- Vaccines and Therapeutics
- Merck KGaA
- Charles River Laboratories
- Eurofins
- SGS
- Sartorius
- Asahi Kasei
- Samsung Biologics
- Syngene
- Intertek
- Minaris Advanced Therapies
- Texcell
- PathoQuest
- Clean Cells
- Avance Biosciences
- Microbiologics
- Alcami
- Creative Biolabs
- Creative Biogene
- WuXi AppTec
- WuXi Biologics
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Viral Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Viral Detection, with revenue, gross margin, and global market share of Viral Detection from 2021 to 2026.
Chapter 3, the Viral Detection competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Viral Detection market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Viral Detection.
Chapter 13, to describe Viral Detection research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Viral Detection by Type
1.3.1 Overview: Global Viral Detection Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Viral Detection Consumption Value Market Share by Type in 2025
1.3.3 Plaque Assays
1.3.4 PCR
1.3.5 ELISA
1.3.6 Others
1.4 Classification of Viral Detection by Service Delivery Format
1.4.1 Overview: Global Viral Detection Market Size by Service Delivery Format: 2021 Versus 2025 Versus 2032
1.4.2 Global Viral Detection Consumption Value Market Share by Service Delivery Format in 2025
1.4.3 Standard Testing Services
1.4.4 Customized Method Development Services
1.4.5 Validation Services
1.4.6 Batch Release Testing Services
1.4.7 Investigation Services
1.4.8 Others
1.5 Classification of Viral Detection by Sample Matrix
1.5.1 Overview: Global Viral Detection Market Size by Sample Matrix: 2021 Versus 2025 Versus 2032
1.5.2 Global Viral Detection Consumption Value Market Share by Sample Matrix in 2025
1.5.3 Raw Materials
1.5.4 Cell Banks
1.5.5 Viral Seed Stocks / Viral Vectors
1.5.6 In-Process Samples
1.5.7 Bulk Harvest / Drug Substance
1.5.8 Final Product
1.5.9 Others
1.6 Classification of Viral Detection by Compliance Level
1.6.1 Overview: Global Viral Detection Market Size by Compliance Level: 2021 Versus 2025 Versus 2032
1.6.2 Global Viral Detection Consumption Value Market Share by Compliance Level in 2025
1.6.3 Research Use Only
1.6.4 Non-GLP / Non-GMP Testing
1.6.5 GLP-compliant Testing
1.6.6 GMP-compliant Testing
1.6.7 Regulatory Submission Support Testing
1.6.8 Others
1.7 Global Viral Detection Market by Application
1.7.1 Overview: Global Viral Detection Market Size by Application: 2021 Versus 2025 Versus 2032
1.7.2 Blood & Blood Products
1.7.3 Cellular & Gene Therapy Products
1.7.4 Stem Cell Products
1.7.5 Tissue & Tissue Products
1.7.6 Vaccines and Therapeutics
1.8 Global Viral Detection Market Size & Forecast
1.9 Global Viral Detection Market Size and Forecast by Region
1.9.1 Global Viral Detection Market Size by Region: 2021 VS 2025 VS 2032
1.9.2 Global Viral Detection Market Size by Region, (2021-2032)
1.9.3 North America Viral Detection Market Size and Prospect (2021-2032)
1.9.4 Europe Viral Detection Market Size and Prospect (2021-2032)
1.9.5 Asia-Pacific Viral Detection Market Size and Prospect (2021-2032)
1.9.6 South America Viral Detection Market Size and Prospect (2021-2032)
1.9.7 Middle East & Africa Viral Detection Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Merck KGaA
2.1.1 Merck KGaA Details
2.1.2 Merck KGaA Major Business
2.1.3 Merck KGaA Viral Detection Product and Solutions
2.1.4 Merck KGaA Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Merck KGaA Recent Developments and Future Plans
2.2 Charles River Laboratories
2.2.1 Charles River Laboratories Details
2.2.2 Charles River Laboratories Major Business
2.2.3 Charles River Laboratories Viral Detection Product and Solutions
2.2.4 Charles River Laboratories Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Charles River Laboratories Recent Developments and Future Plans
2.3 Eurofins
2.3.1 Eurofins Details
2.3.2 Eurofins Major Business
2.3.3 Eurofins Viral Detection Product and Solutions
2.3.4 Eurofins Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Eurofins Recent Developments and Future Plans
2.4 SGS
2.4.1 SGS Details
2.4.2 SGS Major Business
2.4.3 SGS Viral Detection Product and Solutions
2.4.4 SGS Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 SGS Recent Developments and Future Plans
2.5 Sartorius
2.5.1 Sartorius Details
2.5.2 Sartorius Major Business
2.5.3 Sartorius Viral Detection Product and Solutions
2.5.4 Sartorius Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Sartorius Recent Developments and Future Plans
2.6 Asahi Kasei
2.6.1 Asahi Kasei Details
2.6.2 Asahi Kasei Major Business
2.6.3 Asahi Kasei Viral Detection Product and Solutions
2.6.4 Asahi Kasei Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Asahi Kasei Recent Developments and Future Plans
2.7 Samsung Biologics
2.7.1 Samsung Biologics Details
2.7.2 Samsung Biologics Major Business
2.7.3 Samsung Biologics Viral Detection Product and Solutions
2.7.4 Samsung Biologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Samsung Biologics Recent Developments and Future Plans
2.8 Syngene
2.8.1 Syngene Details
2.8.2 Syngene Major Business
2.8.3 Syngene Viral Detection Product and Solutions
2.8.4 Syngene Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Syngene Recent Developments and Future Plans
2.9 Intertek
2.9.1 Intertek Details
2.9.2 Intertek Major Business
2.9.3 Intertek Viral Detection Product and Solutions
2.9.4 Intertek Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Intertek Recent Developments and Future Plans
2.10 Minaris Advanced Therapies
2.10.1 Minaris Advanced Therapies Details
2.10.2 Minaris Advanced Therapies Major Business
2.10.3 Minaris Advanced Therapies Viral Detection Product and Solutions
2.10.4 Minaris Advanced Therapies Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Minaris Advanced Therapies Recent Developments and Future Plans
2.11 Texcell
2.11.1 Texcell Details
2.11.2 Texcell Major Business
2.11.3 Texcell Viral Detection Product and Solutions
2.11.4 Texcell Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Texcell Recent Developments and Future Plans
2.12 PathoQuest
2.12.1 PathoQuest Details
2.12.2 PathoQuest Major Business
2.12.3 PathoQuest Viral Detection Product and Solutions
2.12.4 PathoQuest Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 PathoQuest Recent Developments and Future Plans
2.13 Clean Cells
2.13.1 Clean Cells Details
2.13.2 Clean Cells Major Business
2.13.3 Clean Cells Viral Detection Product and Solutions
2.13.4 Clean Cells Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Clean Cells Recent Developments and Future Plans
2.14 Avance Biosciences
2.14.1 Avance Biosciences Details
2.14.2 Avance Biosciences Major Business
2.14.3 Avance Biosciences Viral Detection Product and Solutions
2.14.4 Avance Biosciences Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Avance Biosciences Recent Developments and Future Plans
2.15 Microbiologics
2.15.1 Microbiologics Details
2.15.2 Microbiologics Major Business
2.15.3 Microbiologics Viral Detection Product and Solutions
2.15.4 Microbiologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Microbiologics Recent Developments and Future Plans
2.16 Alcami
2.16.1 Alcami Details
2.16.2 Alcami Major Business
2.16.3 Alcami Viral Detection Product and Solutions
2.16.4 Alcami Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Alcami Recent Developments and Future Plans
2.17 Creative Biolabs
2.17.1 Creative Biolabs Details
2.17.2 Creative Biolabs Major Business
2.17.3 Creative Biolabs Viral Detection Product and Solutions
2.17.4 Creative Biolabs Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Creative Biolabs Recent Developments and Future Plans
2.18 Creative Biogene
2.18.1 Creative Biogene Details
2.18.2 Creative Biogene Major Business
2.18.3 Creative Biogene Viral Detection Product and Solutions
2.18.4 Creative Biogene Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Creative Biogene Recent Developments and Future Plans
2.19 WuXi AppTec
2.19.1 WuXi AppTec Details
2.19.2 WuXi AppTec Major Business
2.19.3 WuXi AppTec Viral Detection Product and Solutions
2.19.4 WuXi AppTec Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 WuXi AppTec Recent Developments and Future Plans
2.20 WuXi Biologics
2.20.1 WuXi Biologics Details
2.20.2 WuXi Biologics Major Business
2.20.3 WuXi Biologics Viral Detection Product and Solutions
2.20.4 WuXi Biologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 WuXi Biologics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Viral Detection Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Viral Detection by Company Revenue
3.2.2 Top 3 Viral Detection Players Market Share in 2025
3.2.3 Top 6 Viral Detection Players Market Share in 2025
3.3 Viral Detection Market: Overall Company Footprint Analysis
3.3.1 Viral Detection Market: Region Footprint
3.3.2 Viral Detection Market: Company Product Type Footprint
3.3.3 Viral Detection Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Viral Detection Consumption Value and Market Share by Type (2021-2026)
4.2 Global Viral Detection Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Viral Detection Consumption Value Market Share by Application (2021-2026)
5.2 Global Viral Detection Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Viral Detection Consumption Value by Type (2021-2032)
6.2 North America Viral Detection Market Size by Application (2021-2032)
6.3 North America Viral Detection Market Size by Country
6.3.1 North America Viral Detection Consumption Value by Country (2021-2032)
6.3.2 United States Viral Detection Market Size and Forecast (2021-2032)
6.3.3 Canada Viral Detection Market Size and Forecast (2021-2032)
6.3.4 Mexico Viral Detection Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Viral Detection Consumption Value by Type (2021-2032)
7.2 Europe Viral Detection Consumption Value by Application (2021-2032)
7.3 Europe Viral Detection Market Size by Country
7.3.1 Europe Viral Detection Consumption Value by Country (2021-2032)
7.3.2 Germany Viral Detection Market Size and Forecast (2021-2032)
7.3.3 France Viral Detection Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Viral Detection Market Size and Forecast (2021-2032)
7.3.5 Russia Viral Detection Market Size and Forecast (2021-2032)
7.3.6 Italy Viral Detection Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Viral Detection Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Viral Detection Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Viral Detection Market Size by Region
8.3.1 Asia-Pacific Viral Detection Consumption Value by Region (2021-2032)
8.3.2 China Viral Detection Market Size and Forecast (2021-2032)
8.3.3 Japan Viral Detection Market Size and Forecast (2021-2032)
8.3.4 South Korea Viral Detection Market Size and Forecast (2021-2032)
8.3.5 India Viral Detection Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Viral Detection Market Size and Forecast (2021-2032)
8.3.7 Australia Viral Detection Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Viral Detection Consumption Value by Type (2021-2032)
9.2 South America Viral Detection Consumption Value by Application (2021-2032)
9.3 South America Viral Detection Market Size by Country
9.3.1 South America Viral Detection Consumption Value by Country (2021-2032)
9.3.2 Brazil Viral Detection Market Size and Forecast (2021-2032)
9.3.3 Argentina Viral Detection Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Viral Detection Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Viral Detection Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Viral Detection Market Size by Country
10.3.1 Middle East & Africa Viral Detection Consumption Value by Country (2021-2032)
10.3.2 Turkey Viral Detection Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Viral Detection Market Size and Forecast (2021-2032)
10.3.4 UAE Viral Detection Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Viral Detection Market Drivers
11.2 Viral Detection Market Restraints
11.3 Viral Detection Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Viral Detection Industry Chain
12.2 Viral Detection Upstream Analysis
12.3 Viral Detection Midstream Analysis
12.4 Viral Detection Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Viral Detection by Type
1.3.1 Overview: Global Viral Detection Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Viral Detection Consumption Value Market Share by Type in 2025
1.3.3 Plaque Assays
1.3.4 PCR
1.3.5 ELISA
1.3.6 Others
1.4 Classification of Viral Detection by Service Delivery Format
1.4.1 Overview: Global Viral Detection Market Size by Service Delivery Format: 2021 Versus 2025 Versus 2032
1.4.2 Global Viral Detection Consumption Value Market Share by Service Delivery Format in 2025
1.4.3 Standard Testing Services
1.4.4 Customized Method Development Services
1.4.5 Validation Services
1.4.6 Batch Release Testing Services
1.4.7 Investigation Services
1.4.8 Others
1.5 Classification of Viral Detection by Sample Matrix
1.5.1 Overview: Global Viral Detection Market Size by Sample Matrix: 2021 Versus 2025 Versus 2032
1.5.2 Global Viral Detection Consumption Value Market Share by Sample Matrix in 2025
1.5.3 Raw Materials
1.5.4 Cell Banks
1.5.5 Viral Seed Stocks / Viral Vectors
1.5.6 In-Process Samples
1.5.7 Bulk Harvest / Drug Substance
1.5.8 Final Product
1.5.9 Others
1.6 Classification of Viral Detection by Compliance Level
1.6.1 Overview: Global Viral Detection Market Size by Compliance Level: 2021 Versus 2025 Versus 2032
1.6.2 Global Viral Detection Consumption Value Market Share by Compliance Level in 2025
1.6.3 Research Use Only
1.6.4 Non-GLP / Non-GMP Testing
1.6.5 GLP-compliant Testing
1.6.6 GMP-compliant Testing
1.6.7 Regulatory Submission Support Testing
1.6.8 Others
1.7 Global Viral Detection Market by Application
1.7.1 Overview: Global Viral Detection Market Size by Application: 2021 Versus 2025 Versus 2032
1.7.2 Blood & Blood Products
1.7.3 Cellular & Gene Therapy Products
1.7.4 Stem Cell Products
1.7.5 Tissue & Tissue Products
1.7.6 Vaccines and Therapeutics
1.8 Global Viral Detection Market Size & Forecast
1.9 Global Viral Detection Market Size and Forecast by Region
1.9.1 Global Viral Detection Market Size by Region: 2021 VS 2025 VS 2032
1.9.2 Global Viral Detection Market Size by Region, (2021-2032)
1.9.3 North America Viral Detection Market Size and Prospect (2021-2032)
1.9.4 Europe Viral Detection Market Size and Prospect (2021-2032)
1.9.5 Asia-Pacific Viral Detection Market Size and Prospect (2021-2032)
1.9.6 South America Viral Detection Market Size and Prospect (2021-2032)
1.9.7 Middle East & Africa Viral Detection Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Merck KGaA
2.1.1 Merck KGaA Details
2.1.2 Merck KGaA Major Business
2.1.3 Merck KGaA Viral Detection Product and Solutions
2.1.4 Merck KGaA Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Merck KGaA Recent Developments and Future Plans
2.2 Charles River Laboratories
2.2.1 Charles River Laboratories Details
2.2.2 Charles River Laboratories Major Business
2.2.3 Charles River Laboratories Viral Detection Product and Solutions
2.2.4 Charles River Laboratories Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Charles River Laboratories Recent Developments and Future Plans
2.3 Eurofins
2.3.1 Eurofins Details
2.3.2 Eurofins Major Business
2.3.3 Eurofins Viral Detection Product and Solutions
2.3.4 Eurofins Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Eurofins Recent Developments and Future Plans
2.4 SGS
2.4.1 SGS Details
2.4.2 SGS Major Business
2.4.3 SGS Viral Detection Product and Solutions
2.4.4 SGS Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 SGS Recent Developments and Future Plans
2.5 Sartorius
2.5.1 Sartorius Details
2.5.2 Sartorius Major Business
2.5.3 Sartorius Viral Detection Product and Solutions
2.5.4 Sartorius Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Sartorius Recent Developments and Future Plans
2.6 Asahi Kasei
2.6.1 Asahi Kasei Details
2.6.2 Asahi Kasei Major Business
2.6.3 Asahi Kasei Viral Detection Product and Solutions
2.6.4 Asahi Kasei Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Asahi Kasei Recent Developments and Future Plans
2.7 Samsung Biologics
2.7.1 Samsung Biologics Details
2.7.2 Samsung Biologics Major Business
2.7.3 Samsung Biologics Viral Detection Product and Solutions
2.7.4 Samsung Biologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Samsung Biologics Recent Developments and Future Plans
2.8 Syngene
2.8.1 Syngene Details
2.8.2 Syngene Major Business
2.8.3 Syngene Viral Detection Product and Solutions
2.8.4 Syngene Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Syngene Recent Developments and Future Plans
2.9 Intertek
2.9.1 Intertek Details
2.9.2 Intertek Major Business
2.9.3 Intertek Viral Detection Product and Solutions
2.9.4 Intertek Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Intertek Recent Developments and Future Plans
2.10 Minaris Advanced Therapies
2.10.1 Minaris Advanced Therapies Details
2.10.2 Minaris Advanced Therapies Major Business
2.10.3 Minaris Advanced Therapies Viral Detection Product and Solutions
2.10.4 Minaris Advanced Therapies Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Minaris Advanced Therapies Recent Developments and Future Plans
2.11 Texcell
2.11.1 Texcell Details
2.11.2 Texcell Major Business
2.11.3 Texcell Viral Detection Product and Solutions
2.11.4 Texcell Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Texcell Recent Developments and Future Plans
2.12 PathoQuest
2.12.1 PathoQuest Details
2.12.2 PathoQuest Major Business
2.12.3 PathoQuest Viral Detection Product and Solutions
2.12.4 PathoQuest Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 PathoQuest Recent Developments and Future Plans
2.13 Clean Cells
2.13.1 Clean Cells Details
2.13.2 Clean Cells Major Business
2.13.3 Clean Cells Viral Detection Product and Solutions
2.13.4 Clean Cells Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Clean Cells Recent Developments and Future Plans
2.14 Avance Biosciences
2.14.1 Avance Biosciences Details
2.14.2 Avance Biosciences Major Business
2.14.3 Avance Biosciences Viral Detection Product and Solutions
2.14.4 Avance Biosciences Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Avance Biosciences Recent Developments and Future Plans
2.15 Microbiologics
2.15.1 Microbiologics Details
2.15.2 Microbiologics Major Business
2.15.3 Microbiologics Viral Detection Product and Solutions
2.15.4 Microbiologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Microbiologics Recent Developments and Future Plans
2.16 Alcami
2.16.1 Alcami Details
2.16.2 Alcami Major Business
2.16.3 Alcami Viral Detection Product and Solutions
2.16.4 Alcami Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Alcami Recent Developments and Future Plans
2.17 Creative Biolabs
2.17.1 Creative Biolabs Details
2.17.2 Creative Biolabs Major Business
2.17.3 Creative Biolabs Viral Detection Product and Solutions
2.17.4 Creative Biolabs Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Creative Biolabs Recent Developments and Future Plans
2.18 Creative Biogene
2.18.1 Creative Biogene Details
2.18.2 Creative Biogene Major Business
2.18.3 Creative Biogene Viral Detection Product and Solutions
2.18.4 Creative Biogene Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Creative Biogene Recent Developments and Future Plans
2.19 WuXi AppTec
2.19.1 WuXi AppTec Details
2.19.2 WuXi AppTec Major Business
2.19.3 WuXi AppTec Viral Detection Product and Solutions
2.19.4 WuXi AppTec Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 WuXi AppTec Recent Developments and Future Plans
2.20 WuXi Biologics
2.20.1 WuXi Biologics Details
2.20.2 WuXi Biologics Major Business
2.20.3 WuXi Biologics Viral Detection Product and Solutions
2.20.4 WuXi Biologics Viral Detection Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 WuXi Biologics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Viral Detection Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Viral Detection by Company Revenue
3.2.2 Top 3 Viral Detection Players Market Share in 2025
3.2.3 Top 6 Viral Detection Players Market Share in 2025
3.3 Viral Detection Market: Overall Company Footprint Analysis
3.3.1 Viral Detection Market: Region Footprint
3.3.2 Viral Detection Market: Company Product Type Footprint
3.3.3 Viral Detection Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Viral Detection Consumption Value and Market Share by Type (2021-2026)
4.2 Global Viral Detection Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Viral Detection Consumption Value Market Share by Application (2021-2026)
5.2 Global Viral Detection Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Viral Detection Consumption Value by Type (2021-2032)
6.2 North America Viral Detection Market Size by Application (2021-2032)
6.3 North America Viral Detection Market Size by Country
6.3.1 North America Viral Detection Consumption Value by Country (2021-2032)
6.3.2 United States Viral Detection Market Size and Forecast (2021-2032)
6.3.3 Canada Viral Detection Market Size and Forecast (2021-2032)
6.3.4 Mexico Viral Detection Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Viral Detection Consumption Value by Type (2021-2032)
7.2 Europe Viral Detection Consumption Value by Application (2021-2032)
7.3 Europe Viral Detection Market Size by Country
7.3.1 Europe Viral Detection Consumption Value by Country (2021-2032)
7.3.2 Germany Viral Detection Market Size and Forecast (2021-2032)
7.3.3 France Viral Detection Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Viral Detection Market Size and Forecast (2021-2032)
7.3.5 Russia Viral Detection Market Size and Forecast (2021-2032)
7.3.6 Italy Viral Detection Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Viral Detection Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Viral Detection Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Viral Detection Market Size by Region
8.3.1 Asia-Pacific Viral Detection Consumption Value by Region (2021-2032)
8.3.2 China Viral Detection Market Size and Forecast (2021-2032)
8.3.3 Japan Viral Detection Market Size and Forecast (2021-2032)
8.3.4 South Korea Viral Detection Market Size and Forecast (2021-2032)
8.3.5 India Viral Detection Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Viral Detection Market Size and Forecast (2021-2032)
8.3.7 Australia Viral Detection Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Viral Detection Consumption Value by Type (2021-2032)
9.2 South America Viral Detection Consumption Value by Application (2021-2032)
9.3 South America Viral Detection Market Size by Country
9.3.1 South America Viral Detection Consumption Value by Country (2021-2032)
9.3.2 Brazil Viral Detection Market Size and Forecast (2021-2032)
9.3.3 Argentina Viral Detection Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Viral Detection Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Viral Detection Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Viral Detection Market Size by Country
10.3.1 Middle East & Africa Viral Detection Consumption Value by Country (2021-2032)
10.3.2 Turkey Viral Detection Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Viral Detection Market Size and Forecast (2021-2032)
10.3.4 UAE Viral Detection Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Viral Detection Market Drivers
11.2 Viral Detection Market Restraints
11.3 Viral Detection Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Viral Detection Industry Chain
12.2 Viral Detection Upstream Analysis
12.3 Viral Detection Midstream Analysis
12.4 Viral Detection Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Viral Detection Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Viral Detection Consumption Value by Service Delivery Format, (USD Million), 2021 & 2025 & 2032
Table 3. Global Viral Detection Consumption Value by Sample Matrix, (USD Million), 2021 & 2025 & 2032
Table 4. Global Viral Detection Consumption Value by Compliance Level, (USD Million), 2021 & 2025 & 2032
Table 5. Global Viral Detection Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Global Viral Detection Consumption Value by Region (2021-2026) & (USD Million)
Table 7. Global Viral Detection Consumption Value by Region (2027-2032) & (USD Million)
Table 8. Merck KGaA Company Information, Head Office, and Major Competitors
Table 9. Merck KGaA Major Business
Table 10. Merck KGaA Viral Detection Product and Solutions
Table 11. Merck KGaA Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Merck KGaA Recent Developments and Future Plans
Table 13. Charles River Laboratories Company Information, Head Office, and Major Competitors
Table 14. Charles River Laboratories Major Business
Table 15. Charles River Laboratories Viral Detection Product and Solutions
Table 16. Charles River Laboratories Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Charles River Laboratories Recent Developments and Future Plans
Table 18. Eurofins Company Information, Head Office, and Major Competitors
Table 19. Eurofins Major Business
Table 20. Eurofins Viral Detection Product and Solutions
Table 21. Eurofins Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. SGS Company Information, Head Office, and Major Competitors
Table 23. SGS Major Business
Table 24. SGS Viral Detection Product and Solutions
Table 25. SGS Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 26. SGS Recent Developments and Future Plans
Table 27. Sartorius Company Information, Head Office, and Major Competitors
Table 28. Sartorius Major Business
Table 29. Sartorius Viral Detection Product and Solutions
Table 30. Sartorius Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 31. Sartorius Recent Developments and Future Plans
Table 32. Asahi Kasei Company Information, Head Office, and Major Competitors
Table 33. Asahi Kasei Major Business
Table 34. Asahi Kasei Viral Detection Product and Solutions
Table 35. Asahi Kasei Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 36. Asahi Kasei Recent Developments and Future Plans
Table 37. Samsung Biologics Company Information, Head Office, and Major Competitors
Table 38. Samsung Biologics Major Business
Table 39. Samsung Biologics Viral Detection Product and Solutions
Table 40. Samsung Biologics Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 41. Samsung Biologics Recent Developments and Future Plans
Table 42. Syngene Company Information, Head Office, and Major Competitors
Table 43. Syngene Major Business
Table 44. Syngene Viral Detection Product and Solutions
Table 45. Syngene Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 46. Syngene Recent Developments and Future Plans
Table 47. Intertek Company Information, Head Office, and Major Competitors
Table 48. Intertek Major Business
Table 49. Intertek Viral Detection Product and Solutions
Table 50. Intertek Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 51. Intertek Recent Developments and Future Plans
Table 52. Minaris Advanced Therapies Company Information, Head Office, and Major Competitors
Table 53. Minaris Advanced Therapies Major Business
Table 54. Minaris Advanced Therapies Viral Detection Product and Solutions
Table 55. Minaris Advanced Therapies Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 56. Minaris Advanced Therapies Recent Developments and Future Plans
Table 57. Texcell Company Information, Head Office, and Major Competitors
Table 58. Texcell Major Business
Table 59. Texcell Viral Detection Product and Solutions
Table 60. Texcell Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 61. Texcell Recent Developments and Future Plans
Table 62. PathoQuest Company Information, Head Office, and Major Competitors
Table 63. PathoQuest Major Business
Table 64. PathoQuest Viral Detection Product and Solutions
Table 65. PathoQuest Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 66. PathoQuest Recent Developments and Future Plans
Table 67. Clean Cells Company Information, Head Office, and Major Competitors
Table 68. Clean Cells Major Business
Table 69. Clean Cells Viral Detection Product and Solutions
Table 70. Clean Cells Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Clean Cells Recent Developments and Future Plans
Table 72. Avance Biosciences Company Information, Head Office, and Major Competitors
Table 73. Avance Biosciences Major Business
Table 74. Avance Biosciences Viral Detection Product and Solutions
Table 75. Avance Biosciences Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 76. Avance Biosciences Recent Developments and Future Plans
Table 77. Microbiologics Company Information, Head Office, and Major Competitors
Table 78. Microbiologics Major Business
Table 79. Microbiologics Viral Detection Product and Solutions
Table 80. Microbiologics Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 81. Microbiologics Recent Developments and Future Plans
Table 82. Alcami Company Information, Head Office, and Major Competitors
Table 83. Alcami Major Business
Table 84. Alcami Viral Detection Product and Solutions
Table 85. Alcami Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Alcami Recent Developments and Future Plans
Table 87. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 88. Creative Biolabs Major Business
Table 89. Creative Biolabs Viral Detection Product and Solutions
Table 90. Creative Biolabs Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Creative Biolabs Recent Developments and Future Plans
Table 92. Creative Biogene Company Information, Head Office, and Major Competitors
Table 93. Creative Biogene Major Business
Table 94. Creative Biogene Viral Detection Product and Solutions
Table 95. Creative Biogene Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Creative Biogene Recent Developments and Future Plans
Table 97. WuXi AppTec Company Information, Head Office, and Major Competitors
Table 98. WuXi AppTec Major Business
Table 99. WuXi AppTec Viral Detection Product and Solutions
Table 100. WuXi AppTec Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. WuXi AppTec Recent Developments and Future Plans
Table 102. WuXi Biologics Company Information, Head Office, and Major Competitors
Table 103. WuXi Biologics Major Business
Table 104. WuXi Biologics Viral Detection Product and Solutions
Table 105. WuXi Biologics Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 106. WuXi Biologics Recent Developments and Future Plans
Table 107. Global Viral Detection Revenue (USD Million) by Players (2021-2026)
Table 108. Global Viral Detection Revenue Share by Players (2021-2026)
Table 109. Breakdown of Viral Detection by Company Type (Tier 1, Tier 2, and Tier 3)
Table 110. Market Position of Players in Viral Detection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 111. Head Office of Key Viral Detection Players
Table 112. Viral Detection Market: Company Product Type Footprint
Table 113. Viral Detection Market: Company Product Application Footprint
Table 114. Viral Detection New Market Entrants and Barriers to Market Entry
Table 115. Viral Detection Mergers, Acquisition, Agreements, and Collaborations
Table 116. Global Viral Detection Consumption Value (USD Million) by Type (2021-2026)
Table 117. Global Viral Detection Consumption Value Share by Type (2021-2026)
Table 118. Global Viral Detection Consumption Value Forecast by Type (2027-2032)
Table 119. Global Viral Detection Consumption Value by Application (2021-2026)
Table 120. Global Viral Detection Consumption Value Forecast by Application (2027-2032)
Table 121. North America Viral Detection Consumption Value by Type (2021-2026) & (USD Million)
Table 122. North America Viral Detection Consumption Value by Type (2027-2032) & (USD Million)
Table 123. North America Viral Detection Consumption Value by Application (2021-2026) & (USD Million)
Table 124. North America Viral Detection Consumption Value by Application (2027-2032) & (USD Million)
Table 125. North America Viral Detection Consumption Value by Country (2021-2026) & (USD Million)
Table 126. North America Viral Detection Consumption Value by Country (2027-2032) & (USD Million)
Table 127. Europe Viral Detection Consumption Value by Type (2021-2026) & (USD Million)
Table 128. Europe Viral Detection Consumption Value by Type (2027-2032) & (USD Million)
Table 129. Europe Viral Detection Consumption Value by Application (2021-2026) & (USD Million)
Table 130. Europe Viral Detection Consumption Value by Application (2027-2032) & (USD Million)
Table 131. Europe Viral Detection Consumption Value by Country (2021-2026) & (USD Million)
Table 132. Europe Viral Detection Consumption Value by Country (2027-2032) & (USD Million)
Table 133. Asia-Pacific Viral Detection Consumption Value by Type (2021-2026) & (USD Million)
Table 134. Asia-Pacific Viral Detection Consumption Value by Type (2027-2032) & (USD Million)
Table 135. Asia-Pacific Viral Detection Consumption Value by Application (2021-2026) & (USD Million)
Table 136. Asia-Pacific Viral Detection Consumption Value by Application (2027-2032) & (USD Million)
Table 137. Asia-Pacific Viral Detection Consumption Value by Region (2021-2026) & (USD Million)
Table 138. Asia-Pacific Viral Detection Consumption Value by Region (2027-2032) & (USD Million)
Table 139. South America Viral Detection Consumption Value by Type (2021-2026) & (USD Million)
Table 140. South America Viral Detection Consumption Value by Type (2027-2032) & (USD Million)
Table 141. South America Viral Detection Consumption Value by Application (2021-2026) & (USD Million)
Table 142. South America Viral Detection Consumption Value by Application (2027-2032) & (USD Million)
Table 143. South America Viral Detection Consumption Value by Country (2021-2026) & (USD Million)
Table 144. South America Viral Detection Consumption Value by Country (2027-2032) & (USD Million)
Table 145. Middle East & Africa Viral Detection Consumption Value by Type (2021-2026) & (USD Million)
Table 146. Middle East & Africa Viral Detection Consumption Value by Type (2027-2032) & (USD Million)
Table 147. Middle East & Africa Viral Detection Consumption Value by Application (2021-2026) & (USD Million)
Table 148. Middle East & Africa Viral Detection Consumption Value by Application (2027-2032) & (USD Million)
Table 149. Middle East & Africa Viral Detection Consumption Value by Country (2021-2026) & (USD Million)
Table 150. Middle East & Africa Viral Detection Consumption Value by Country (2027-2032) & (USD Million)
Table 151. Global Key Players of Viral Detection Upstream (Raw Materials)
Table 152. Global Viral Detection Typical Customers
Table 1. Global Viral Detection Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Viral Detection Consumption Value by Service Delivery Format, (USD Million), 2021 & 2025 & 2032
Table 3. Global Viral Detection Consumption Value by Sample Matrix, (USD Million), 2021 & 2025 & 2032
Table 4. Global Viral Detection Consumption Value by Compliance Level, (USD Million), 2021 & 2025 & 2032
Table 5. Global Viral Detection Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Global Viral Detection Consumption Value by Region (2021-2026) & (USD Million)
Table 7. Global Viral Detection Consumption Value by Region (2027-2032) & (USD Million)
Table 8. Merck KGaA Company Information, Head Office, and Major Competitors
Table 9. Merck KGaA Major Business
Table 10. Merck KGaA Viral Detection Product and Solutions
Table 11. Merck KGaA Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Merck KGaA Recent Developments and Future Plans
Table 13. Charles River Laboratories Company Information, Head Office, and Major Competitors
Table 14. Charles River Laboratories Major Business
Table 15. Charles River Laboratories Viral Detection Product and Solutions
Table 16. Charles River Laboratories Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Charles River Laboratories Recent Developments and Future Plans
Table 18. Eurofins Company Information, Head Office, and Major Competitors
Table 19. Eurofins Major Business
Table 20. Eurofins Viral Detection Product and Solutions
Table 21. Eurofins Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. SGS Company Information, Head Office, and Major Competitors
Table 23. SGS Major Business
Table 24. SGS Viral Detection Product and Solutions
Table 25. SGS Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 26. SGS Recent Developments and Future Plans
Table 27. Sartorius Company Information, Head Office, and Major Competitors
Table 28. Sartorius Major Business
Table 29. Sartorius Viral Detection Product and Solutions
Table 30. Sartorius Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 31. Sartorius Recent Developments and Future Plans
Table 32. Asahi Kasei Company Information, Head Office, and Major Competitors
Table 33. Asahi Kasei Major Business
Table 34. Asahi Kasei Viral Detection Product and Solutions
Table 35. Asahi Kasei Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 36. Asahi Kasei Recent Developments and Future Plans
Table 37. Samsung Biologics Company Information, Head Office, and Major Competitors
Table 38. Samsung Biologics Major Business
Table 39. Samsung Biologics Viral Detection Product and Solutions
Table 40. Samsung Biologics Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 41. Samsung Biologics Recent Developments and Future Plans
Table 42. Syngene Company Information, Head Office, and Major Competitors
Table 43. Syngene Major Business
Table 44. Syngene Viral Detection Product and Solutions
Table 45. Syngene Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 46. Syngene Recent Developments and Future Plans
Table 47. Intertek Company Information, Head Office, and Major Competitors
Table 48. Intertek Major Business
Table 49. Intertek Viral Detection Product and Solutions
Table 50. Intertek Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 51. Intertek Recent Developments and Future Plans
Table 52. Minaris Advanced Therapies Company Information, Head Office, and Major Competitors
Table 53. Minaris Advanced Therapies Major Business
Table 54. Minaris Advanced Therapies Viral Detection Product and Solutions
Table 55. Minaris Advanced Therapies Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 56. Minaris Advanced Therapies Recent Developments and Future Plans
Table 57. Texcell Company Information, Head Office, and Major Competitors
Table 58. Texcell Major Business
Table 59. Texcell Viral Detection Product and Solutions
Table 60. Texcell Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 61. Texcell Recent Developments and Future Plans
Table 62. PathoQuest Company Information, Head Office, and Major Competitors
Table 63. PathoQuest Major Business
Table 64. PathoQuest Viral Detection Product and Solutions
Table 65. PathoQuest Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 66. PathoQuest Recent Developments and Future Plans
Table 67. Clean Cells Company Information, Head Office, and Major Competitors
Table 68. Clean Cells Major Business
Table 69. Clean Cells Viral Detection Product and Solutions
Table 70. Clean Cells Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Clean Cells Recent Developments and Future Plans
Table 72. Avance Biosciences Company Information, Head Office, and Major Competitors
Table 73. Avance Biosciences Major Business
Table 74. Avance Biosciences Viral Detection Product and Solutions
Table 75. Avance Biosciences Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 76. Avance Biosciences Recent Developments and Future Plans
Table 77. Microbiologics Company Information, Head Office, and Major Competitors
Table 78. Microbiologics Major Business
Table 79. Microbiologics Viral Detection Product and Solutions
Table 80. Microbiologics Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 81. Microbiologics Recent Developments and Future Plans
Table 82. Alcami Company Information, Head Office, and Major Competitors
Table 83. Alcami Major Business
Table 84. Alcami Viral Detection Product and Solutions
Table 85. Alcami Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Alcami Recent Developments and Future Plans
Table 87. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 88. Creative Biolabs Major Business
Table 89. Creative Biolabs Viral Detection Product and Solutions
Table 90. Creative Biolabs Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Creative Biolabs Recent Developments and Future Plans
Table 92. Creative Biogene Company Information, Head Office, and Major Competitors
Table 93. Creative Biogene Major Business
Table 94. Creative Biogene Viral Detection Product and Solutions
Table 95. Creative Biogene Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Creative Biogene Recent Developments and Future Plans
Table 97. WuXi AppTec Company Information, Head Office, and Major Competitors
Table 98. WuXi AppTec Major Business
Table 99. WuXi AppTec Viral Detection Product and Solutions
Table 100. WuXi AppTec Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. WuXi AppTec Recent Developments and Future Plans
Table 102. WuXi Biologics Company Information, Head Office, and Major Competitors
Table 103. WuXi Biologics Major Business
Table 104. WuXi Biologics Viral Detection Product and Solutions
Table 105. WuXi Biologics Viral Detection Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 106. WuXi Biologics Recent Developments and Future Plans
Table 107. Global Viral Detection Revenue (USD Million) by Players (2021-2026)
Table 108. Global Viral Detection Revenue Share by Players (2021-2026)
Table 109. Breakdown of Viral Detection by Company Type (Tier 1, Tier 2, and Tier 3)
Table 110. Market Position of Players in Viral Detection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 111. Head Office of Key Viral Detection Players
Table 112. Viral Detection Market: Company Product Type Footprint
Table 113. Viral Detection Market: Company Product Application Footprint
Table 114. Viral Detection New Market Entrants and Barriers to Market Entry
Table 115. Viral Detection Mergers, Acquisition, Agreements, and Collaborations
Table 116. Global Viral Detection Consumption Value (USD Million) by Type (2021-2026)
Table 117. Global Viral Detection Consumption Value Share by Type (2021-2026)
Table 118. Global Viral Detection Consumption Value Forecast by Type (2027-2032)
Table 119. Global Viral Detection Consumption Value by Application (2021-2026)
Table 120. Global Viral Detection Consumption Value Forecast by Application (2027-2032)
Table 121. North America Viral Detection Consumption Value by Type (2021-2026) & (USD Million)
Table 122. North America Viral Detection Consumption Value by Type (2027-2032) & (USD Million)
Table 123. North America Viral Detection Consumption Value by Application (2021-2026) & (USD Million)
Table 124. North America Viral Detection Consumption Value by Application (2027-2032) & (USD Million)
Table 125. North America Viral Detection Consumption Value by Country (2021-2026) & (USD Million)
Table 126. North America Viral Detection Consumption Value by Country (2027-2032) & (USD Million)
Table 127. Europe Viral Detection Consumption Value by Type (2021-2026) & (USD Million)
Table 128. Europe Viral Detection Consumption Value by Type (2027-2032) & (USD Million)
Table 129. Europe Viral Detection Consumption Value by Application (2021-2026) & (USD Million)
Table 130. Europe Viral Detection Consumption Value by Application (2027-2032) & (USD Million)
Table 131. Europe Viral Detection Consumption Value by Country (2021-2026) & (USD Million)
Table 132. Europe Viral Detection Consumption Value by Country (2027-2032) & (USD Million)
Table 133. Asia-Pacific Viral Detection Consumption Value by Type (2021-2026) & (USD Million)
Table 134. Asia-Pacific Viral Detection Consumption Value by Type (2027-2032) & (USD Million)
Table 135. Asia-Pacific Viral Detection Consumption Value by Application (2021-2026) & (USD Million)
Table 136. Asia-Pacific Viral Detection Consumption Value by Application (2027-2032) & (USD Million)
Table 137. Asia-Pacific Viral Detection Consumption Value by Region (2021-2026) & (USD Million)
Table 138. Asia-Pacific Viral Detection Consumption Value by Region (2027-2032) & (USD Million)
Table 139. South America Viral Detection Consumption Value by Type (2021-2026) & (USD Million)
Table 140. South America Viral Detection Consumption Value by Type (2027-2032) & (USD Million)
Table 141. South America Viral Detection Consumption Value by Application (2021-2026) & (USD Million)
Table 142. South America Viral Detection Consumption Value by Application (2027-2032) & (USD Million)
Table 143. South America Viral Detection Consumption Value by Country (2021-2026) & (USD Million)
Table 144. South America Viral Detection Consumption Value by Country (2027-2032) & (USD Million)
Table 145. Middle East & Africa Viral Detection Consumption Value by Type (2021-2026) & (USD Million)
Table 146. Middle East & Africa Viral Detection Consumption Value by Type (2027-2032) & (USD Million)
Table 147. Middle East & Africa Viral Detection Consumption Value by Application (2021-2026) & (USD Million)
Table 148. Middle East & Africa Viral Detection Consumption Value by Application (2027-2032) & (USD Million)
Table 149. Middle East & Africa Viral Detection Consumption Value by Country (2021-2026) & (USD Million)
Table 150. Middle East & Africa Viral Detection Consumption Value by Country (2027-2032) & (USD Million)
Table 151. Global Key Players of Viral Detection Upstream (Raw Materials)
Table 152. Global Viral Detection Typical Customers
LIST OF FIGURES
Figure 1. Viral Detection Picture
Figure 2. Global Viral Detection Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Viral Detection Consumption Value Market Share by Type in 2025
Figure 4. Plaque Assays
Figure 5. PCR
Figure 6. ELISA
Figure 7. Others
Figure 8. Global Viral Detection Consumption Value by Service Delivery Format, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Viral Detection Consumption Value Market Share by Service Delivery Format in 2025
Figure 10. Standard Testing Services
Figure 11. Customized Method Development Services
Figure 12. Validation Services
Figure 13. Batch Release Testing Services
Figure 14. Investigation Services
Figure 15. Others
Figure 16. Global Viral Detection Consumption Value by Sample Matrix, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Viral Detection Consumption Value Market Share by Sample Matrix in 2025
Figure 18. Raw Materials
Figure 19. Cell Banks
Figure 20. Viral Seed Stocks / Viral Vectors
Figure 21. In-Process Samples
Figure 22. Bulk Harvest / Drug Substance
Figure 23. Final Product
Figure 24. Others
Figure 25. Global Viral Detection Consumption Value by Compliance Level, (USD Million), 2021 & 2025 & 2032
Figure 26. Global Viral Detection Consumption Value Market Share by Compliance Level in 2025
Figure 27. Research Use Only
Figure 28. Non-GLP / Non-GMP Testing
Figure 29. GLP-compliant Testing
Figure 30. GMP-compliant Testing
Figure 31. Regulatory Submission Support Testing
Figure 32. Others
Figure 33. Global Viral Detection Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 34. Viral Detection Consumption Value Market Share by Application in 2025
Figure 35. Blood & Blood Products Picture
Figure 36. Cellular & Gene Therapy Products Picture
Figure 37. Stem Cell Products Picture
Figure 38. Tissue & Tissue Products Picture
Figure 39. Vaccines and Therapeutics Picture
Figure 40. Global Viral Detection Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 41. Global Viral Detection Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 42. Global Market Viral Detection Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 43. Global Viral Detection Consumption Value Market Share by Region (2021-2032)
Figure 44. Global Viral Detection Consumption Value Market Share by Region in 2025
Figure 45. North America Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 46. Europe Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 47. Asia-Pacific Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 48. South America Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 49. Middle East & Africa Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 50. Company Three Recent Developments and Future Plans
Figure 51. Global Viral Detection Revenue Share by Players in 2025
Figure 52. Viral Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 53. Market Share of Viral Detection by Player Revenue in 2025
Figure 54. Top 3 Viral Detection Players Market Share in 2025
Figure 55. Top 6 Viral Detection Players Market Share in 2025
Figure 56. Global Viral Detection Consumption Value Share by Type (2021-2026)
Figure 57. Global Viral Detection Market Share Forecast by Type (2027-2032)
Figure 58. Global Viral Detection Consumption Value Share by Application (2021-2026)
Figure 59. Global Viral Detection Market Share Forecast by Application (2027-2032)
Figure 60. North America Viral Detection Consumption Value Market Share by Type (2021-2032)
Figure 61. North America Viral Detection Consumption Value Market Share by Application (2021-2032)
Figure 62. North America Viral Detection Consumption Value Market Share by Country (2021-2032)
Figure 63. United States Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 64. Canada Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 65. Mexico Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 66. Europe Viral Detection Consumption Value Market Share by Type (2021-2032)
Figure 67. Europe Viral Detection Consumption Value Market Share by Application (2021-2032)
Figure 68. Europe Viral Detection Consumption Value Market Share by Country (2021-2032)
Figure 69. Germany Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 70. France Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 71. United Kingdom Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 72. Russia Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 73. Italy Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 74. Asia-Pacific Viral Detection Consumption Value Market Share by Type (2021-2032)
Figure 75. Asia-Pacific Viral Detection Consumption Value Market Share by Application (2021-2032)
Figure 76. Asia-Pacific Viral Detection Consumption Value Market Share by Region (2021-2032)
Figure 77. China Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 78. Japan Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 79. South Korea Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 80. India Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 81. Southeast Asia Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 82. Australia Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 83. South America Viral Detection Consumption Value Market Share by Type (2021-2032)
Figure 84. South America Viral Detection Consumption Value Market Share by Application (2021-2032)
Figure 85. South America Viral Detection Consumption Value Market Share by Country (2021-2032)
Figure 86. Brazil Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 87. Argentina Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 88. Middle East & Africa Viral Detection Consumption Value Market Share by Type (2021-2032)
Figure 89. Middle East & Africa Viral Detection Consumption Value Market Share by Application (2021-2032)
Figure 90. Middle East & Africa Viral Detection Consumption Value Market Share by Country (2021-2032)
Figure 91. Turkey Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 92. Saudi Arabia Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 93. UAE Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 94. Viral Detection Market Drivers
Figure 95. Viral Detection Market Restraints
Figure 96. Viral Detection Market Trends
Figure 97. Porters Five Forces Analysis
Figure 98. Viral Detection Industrial Chain
Figure 99. Methodology
Figure 100. Research Process and Data Source
Figure 1. Viral Detection Picture
Figure 2. Global Viral Detection Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Viral Detection Consumption Value Market Share by Type in 2025
Figure 4. Plaque Assays
Figure 5. PCR
Figure 6. ELISA
Figure 7. Others
Figure 8. Global Viral Detection Consumption Value by Service Delivery Format, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Viral Detection Consumption Value Market Share by Service Delivery Format in 2025
Figure 10. Standard Testing Services
Figure 11. Customized Method Development Services
Figure 12. Validation Services
Figure 13. Batch Release Testing Services
Figure 14. Investigation Services
Figure 15. Others
Figure 16. Global Viral Detection Consumption Value by Sample Matrix, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Viral Detection Consumption Value Market Share by Sample Matrix in 2025
Figure 18. Raw Materials
Figure 19. Cell Banks
Figure 20. Viral Seed Stocks / Viral Vectors
Figure 21. In-Process Samples
Figure 22. Bulk Harvest / Drug Substance
Figure 23. Final Product
Figure 24. Others
Figure 25. Global Viral Detection Consumption Value by Compliance Level, (USD Million), 2021 & 2025 & 2032
Figure 26. Global Viral Detection Consumption Value Market Share by Compliance Level in 2025
Figure 27. Research Use Only
Figure 28. Non-GLP / Non-GMP Testing
Figure 29. GLP-compliant Testing
Figure 30. GMP-compliant Testing
Figure 31. Regulatory Submission Support Testing
Figure 32. Others
Figure 33. Global Viral Detection Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 34. Viral Detection Consumption Value Market Share by Application in 2025
Figure 35. Blood & Blood Products Picture
Figure 36. Cellular & Gene Therapy Products Picture
Figure 37. Stem Cell Products Picture
Figure 38. Tissue & Tissue Products Picture
Figure 39. Vaccines and Therapeutics Picture
Figure 40. Global Viral Detection Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 41. Global Viral Detection Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 42. Global Market Viral Detection Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 43. Global Viral Detection Consumption Value Market Share by Region (2021-2032)
Figure 44. Global Viral Detection Consumption Value Market Share by Region in 2025
Figure 45. North America Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 46. Europe Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 47. Asia-Pacific Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 48. South America Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 49. Middle East & Africa Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 50. Company Three Recent Developments and Future Plans
Figure 51. Global Viral Detection Revenue Share by Players in 2025
Figure 52. Viral Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 53. Market Share of Viral Detection by Player Revenue in 2025
Figure 54. Top 3 Viral Detection Players Market Share in 2025
Figure 55. Top 6 Viral Detection Players Market Share in 2025
Figure 56. Global Viral Detection Consumption Value Share by Type (2021-2026)
Figure 57. Global Viral Detection Market Share Forecast by Type (2027-2032)
Figure 58. Global Viral Detection Consumption Value Share by Application (2021-2026)
Figure 59. Global Viral Detection Market Share Forecast by Application (2027-2032)
Figure 60. North America Viral Detection Consumption Value Market Share by Type (2021-2032)
Figure 61. North America Viral Detection Consumption Value Market Share by Application (2021-2032)
Figure 62. North America Viral Detection Consumption Value Market Share by Country (2021-2032)
Figure 63. United States Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 64. Canada Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 65. Mexico Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 66. Europe Viral Detection Consumption Value Market Share by Type (2021-2032)
Figure 67. Europe Viral Detection Consumption Value Market Share by Application (2021-2032)
Figure 68. Europe Viral Detection Consumption Value Market Share by Country (2021-2032)
Figure 69. Germany Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 70. France Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 71. United Kingdom Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 72. Russia Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 73. Italy Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 74. Asia-Pacific Viral Detection Consumption Value Market Share by Type (2021-2032)
Figure 75. Asia-Pacific Viral Detection Consumption Value Market Share by Application (2021-2032)
Figure 76. Asia-Pacific Viral Detection Consumption Value Market Share by Region (2021-2032)
Figure 77. China Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 78. Japan Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 79. South Korea Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 80. India Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 81. Southeast Asia Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 82. Australia Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 83. South America Viral Detection Consumption Value Market Share by Type (2021-2032)
Figure 84. South America Viral Detection Consumption Value Market Share by Application (2021-2032)
Figure 85. South America Viral Detection Consumption Value Market Share by Country (2021-2032)
Figure 86. Brazil Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 87. Argentina Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 88. Middle East & Africa Viral Detection Consumption Value Market Share by Type (2021-2032)
Figure 89. Middle East & Africa Viral Detection Consumption Value Market Share by Application (2021-2032)
Figure 90. Middle East & Africa Viral Detection Consumption Value Market Share by Country (2021-2032)
Figure 91. Turkey Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 92. Saudi Arabia Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 93. UAE Viral Detection Consumption Value (2021-2032) & (USD Million)
Figure 94. Viral Detection Market Drivers
Figure 95. Viral Detection Market Restraints
Figure 96. Viral Detection Market Trends
Figure 97. Porters Five Forces Analysis
Figure 98. Viral Detection Industrial Chain
Figure 99. Methodology
Figure 100. Research Process and Data Source
